Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$1.45 -0.04 (-2.68%)
2/9/2010 4:00 PM

AVI BioPharma, Inc. (AVII)

CAPS Rating:
****

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

AVII doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

143 Outperforms
13 Underperforms
 

All-Stars

31 Outperforms
3 Underperforms
 

Wall Street

2 Outperforms
1 Underperforms
 

Members bullish on AVII are also bullish on:

Members bearish on AVII are also bearish on:

Ticker Tags

Aggressive Growth (860), Healthcare (711), Defensive (1457), Growth (1902), Biotechnology (220), Micro Cap (4701)
Suggest a tag

AVI BioPharma, Inc. At A Glance

Current Price: $1.45
Last Trade Time: 2/9/2010 4:00 PM
Open: $1.50
Previous Close: $1.49
Daily Range: $1.42 - $1.51
52-Week Range: $0.52 - $2.73
Volume: 733,126
Market Cap: $160.13M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

AVII VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

AVI BioPharma, Inc. (AVII)

Avatar mjrruby (< 20) Submitted: 10/06/09 4:04 PM

Just read Barons issue of Oct.5, 2009

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 32 :   1 2 3 4 5 Next »

Show Pitch Replies

Recs

0

 (AVII)

Avatar siliconwafer (40.78) Submitted: 1/18/10 2:57 PM : Outperform Start Price: $1.65 AVII Score: -6.49

AVII has a great product pipe-line. This is a great longer-term play if you can buy on dips and can stomach some up and down until the company sees results. Might be some time before product is brought to market so patience is needed, but I am confident patient investors will reap rewards in 5 years time.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVII)

Avatar ruff33 (40.25) Submitted: 1/04/10 8:36 PM : Outperform Start Price: $1.58 AVII Score: -2.89

Jerry lewis-fighting MD-but, really it is. Things just are panning out.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (AVII)

Avatar thiscoloradokid (< 20) Submitted: 12/15/09 12:33 PM : Outperform Start Price: $1.56 AVII Score: -3.11

Low and rising technical pattern.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVII)

Avatar Paulson545 (< 20) Submitted: 12/08/09 1:43 PM : Outperform Start Price: $1.58 AVII Score: -5.84

I watched HGSI go in one year from 40 cents to $28.00 with approval of its Lupus drug. If AVII gets approval of its MD drug i believe it will soar.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVII)

Avatar brianpetro13 (28.84) Submitted: 11/09/09 3:37 PM : Outperform Start Price: $1.50 AVII Score: -1.38

This stock is still performing strong even after today's quarterly report which was worse than expected. If that doesn't hold this stock down than I can't see anything in the immediate future which would reverse it's direction.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 32 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRodmanRen < 20 08/13/07 Outperform NS $2.89-49.83%-22.96%-26.87
TrackMaximGroup < 20 03/30/07 Outperform NS $2.53-42.69%-20.31%-22.38
TrackJimCramer < 20 03/15/06 Underperform 3W $6.95-79.14%-11.81%+67.33

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 218ms